Thoracic surgery
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age = 18 age =75 years old, male or female; (2) Endoscopic surgery is required, and there are indications for surgical treatment of segmentectomyt/lobectomy;Among them, the pre-trial subjects were not limited to the type of surgery, and the investigator judged that they had the indications for thoracic surgery; (3) preoperative ASA graded grade I-III; (4) The subject voluntarily participates in the clinical trial, and agrees or signs the informed consent form with the consent of his or her guardian; (5) Willing to cooperate and complete trial follow-up and related examinations
Exclusion criteria
Exclusion criteria: (1) Those who have a history of thoracic surgery or other malignant tumors in the past and are judged by the investigator to be unsuitable for enrollment; (2) Those with serious comorbidities (heart, lung, liver, brain, kidney and other diseases) or weak constitution that cannot tolerate general anesthesia or surgery; (3) Those with severe bleeding tendency or coagulation dysfunction; (4) Those who are in the active period of infectious diseases or have other severe non-communicable infections; (5) Immunodeficiency virus (HIV) antibody positive; Treponemal-positive patients; (6) Those with severe allergies, suspected or determined to have alcohol, drugs or drug addiction; (7) Those with a history of epilepsy or psychiatric illness or cognitive impairment; (8) Women who are pregnant, lactating, or planning to become pregnant during the test; (9) Participation in other interventional clinical trials within 3 months prior to signing informed consent; (10) Other situations that the investigator believes is not suitable to participate in this clinical trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Blood loss;Operation time;Hospital stays;Postoperation pain score;Surgeon's satisfaction socre ;Blood transfusion rate; | — |
Primary
| Measure | Time frame |
|---|---|
| Surgical success rate; | — |
Countries
China
Contacts
Public ContactJianxing He
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed